Article
Cardiac & Cardiovascular Systems
Ramon Luengo-Fernandez, Marjan Walli-Attaei, Alastair Gray, Aleksandra Torbica, Aldo P. Maggioni, Radu Huculeci, Firoozeh Bairami, Victor Aboyans, Adam D. Timmis, Panos Vardas, Jose Leal
Summary: The study found that cardiovascular disease costs the EU 282 billion annually, with 55% allocated to health and long-term care, accounting for 11% of EU health expenditure. This provides important evidence for policymaking to address the economic burden of CVD.
EUROPEAN HEART JOURNAL
(2023)
Review
Respiratory System
Alyson W. Wong, John Koo, Christopher J. Ryerson, Mohsen Sadatsafavi, Wenjia Chen
Summary: The economic burden of interstitial lung disease (ILD) is consistently high in all countries, with the cost-effectiveness profiles of new therapies generally being undesirable. The median total direct cost for ILD globally equates to 51% of a country's GDP per capita and has been increasing over time.
BMC PULMONARY MEDICINE
(2022)
Article
Economics
Margherita d'Errico, Milena Pavlova, Federico Spandonaro
Summary: Obesity in Italy is associated with significant direct and indirect costs, totaling 13.34 billion euros in 2020. Cardiovascular diseases have the highest impact on direct costs, while absenteeism and presenteeism contribute equally to indirect costs. Containing this public health threat in Italy requires cost-effective prevention programs.
EUROPEAN JOURNAL OF HEALTH ECONOMICS
(2022)
Article
Cardiac & Cardiovascular Systems
Ciaran N. Kohli-Lynch, James Lewsey, Kathleen A. Boyd, Dustin D. French, Neil Jordan, Andrew E. Moran, Naveed Sattar, David Preiss, Andrew H. Briggs
Summary: This study evaluates the cost-effectiveness of expanding preventive statin eligibility and novel approaches to prioritization from a Scottish health sector perspective. The findings suggest that generic pricing has made preventive statin therapy cost-effective for many adults. Additionally, an approach using absolute risk reduction (ARR)-guided therapy is more effective and cost-effective than the traditional method based on 10-year risk assessment.
Article
Cardiac & Cardiovascular Systems
Ka-Chun Li, Liping Huang, Maoyi Tian, Gian Luca Di Tanna, Jie Yu, Xinyi Zhang, Xuejun Yin, Yishu Liu, Zhixin Hao, Bo Zhou, Xiangxian Feng, Zhifang Li, Jianxin Zhang, Jixin Sun, Yuhong Zhang, Yi Zhao, Ruijuan Zhang, Yan Yu, Nicole Li, Lijing L. Yan, Darwin R. Labarthe, Paul Elliott, Yangfeng Wu, Bruce Neal, Thomas Lung, Lei Si
Summary: This study assessed the cost-effectiveness of replacing regular salt with a reduced-sodium, added-potassium salt substitute in individuals with previous stroke or uncontrolled high blood pressure living in rural China. The results showed that this intervention reduced the risk of stroke, improved quality of life, and had lower costs.
Article
Peripheral Vascular Disease
Kelsey B. Bryant, Aditi S. Rao, Laura P. Cohen, Nadine Dandan, Ian M. Kronish, Nikita Barai, Valy Fontil, Yiyi Zhang, Andrew E. Moran, Brandon K. Bellows
Summary: Team-based care with nonphysician titration is an effective and cost-effective strategy for managing blood pressure, leading to superior outcomes compared to other strategies and reducing hypertension-related morbidity and mortality.
Review
Medicine, General & Internal
Ami Schattner
Summary: Mortality is increased in rheumatoid arthritis, primarily due to cardiovascular diseases. The pathogenesis involves accelerated atherosclerosis and chronic inflammation. The best cardiovascular protection is achieved by early suppression of inflammation and disease activity, as well as addressing traditional risk factors.
AMERICAN JOURNAL OF MEDICINE
(2023)
Review
Clinical Neurology
Steven Simoens
Summary: The economic burden of multiple sclerosis is substantial, with costs increasing with disease severity and influenced by relapses and therapy adherence. Cost estimates vary between countries, and disease-modifying therapies are generally not cost-effective for relapsing-remitting multiple sclerosis, depending on the local setting.
FRONTIERS IN NEUROLOGY
(2022)
Article
Ophthalmology
Junxing Chay, Rachael Wei Chao Tang, Tien-En Tan, Choi Mun Chan, Ranjana Mathur, Brian J. H. Lee, Hiok Hong Chan, Shaun S. K. P. Sim, Saadia Farooqui, Kelvin Y. C. Teo, Eva K. Fenwick, Ecosse L. Lamoureux, Chui Ming Gemmy Cheung, Beau J. Fenner
Summary: This study aimed to assess the economic impact of inherited retinal disease (IRD) among Singaporeans. The study found that while employment rates were the same as the general population, patients with IRD had significantly lower income. Economic losses were driven by male patients and those with early age of onset, while direct healthcare costs contributed relatively little to the financial burden.
Article
Peripheral Vascular Disease
Margaret Constanti, Christopher N. Floyd, Mark Glover, Rebecca Boffa, Anthony S. Wierzbicki, Richard J. McManus
Summary: This study indicates that initiating antihypertensive drug treatment for adults with stage 1 hypertension at the age of 60 is cost-effective regardless of their 10-year cardiovascular disease risk level. The treatment is cost-effective for men of all ages and women over 60. For other age groups, treatment is also cost-effective regardless of risk, except for younger women.
Article
Engineering, Industrial
Noah C. Dormady, Adam Rose, Alfredo Roa-Henriquez, C. Blain Morin
Summary: This paper introduces the concept of resilience into economic production theory and empirically analyzes the cost-effectiveness of resilience strategies. The results show that resilience tactics can significantly reduce business interruption losses.
INTERNATIONAL JOURNAL OF PRODUCTION ECONOMICS
(2022)
Review
Oncology
David Cantarero-Prieto, Javier Lera, Paloma Lanza-Leon, Marina Barreda-Gutierrez, Vicente Guillem-Porta, Luis Castelo-Branco, Jose M. Martin-Moreno
Summary: Prostate cancer is a common and impactful disease for men, with no clear consensus on the most effective treatment strategy. This article analyzes data from OECD countries to characterize the economic burden and cost-effectiveness of different treatment strategies for localized prostate cancer.
Article
Health Care Sciences & Services
Mariano Matilla-Garcia, Paloma Ubeda Molla, Fernando Sanchez Martinez, Albert Ariza-Sole, Rocio Gomez-Lopez, Esteban Lopez de Sa, Ricard Ferrer
Summary: Cardiac arrest is a significant public health issue in Europe, and it is associated with a large socioeconomic burden. This study analyzes the economic burden of cardiac arrest in Spain and evaluates the cost-effectiveness of key interventions, particularly regarding neurological outcomes at discharge.
BMC HEALTH SERVICES RESEARCH
(2023)
Review
Cardiac & Cardiovascular Systems
Gemma E. Shields, Aleix Rowlandson, Garima Dalal, Stuart Nickerson, Holly Cranmer, Lora Capobianco, Patrick Doherty
Summary: This review found that home-based cardiac rehabilitation (CR) interventions are cost-effective compared to centre-based options. However, the evidence base is limited in size and heterogeneous in methods, and there are several limitations that need to be addressed in future research.
Article
Cardiac & Cardiovascular Systems
Chia-Te Liao, Chun-Ting Yang, Pin-Hao Chen, Han Siong Toh, Shihchen Kuo, Zhih-Cherng Chen, Huang-Tz Ou, Nai-Ying Ko, Jung-Der Wang
Summary: There is a high economic burden of incident cardiovascular diseases in HIV-infected population, which varies depending on the adherence to antiretroviral therapy (ART). Patients with higher adherence to ART have lower economic impact from CVDs.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY
(2021)
